Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

Simmons, 2010, The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation, Diabetologia, 53, 600, 10.1007/s00125-009-1620-4

Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644

Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595

Kotronen, 2007, Liver fat in the metabolic syndrome, J Clin Endocrinol Metab, 92, 3490, 10.1210/jc.2007-0482

Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 142, 1592, 10.1053/j.gastro.2012.04.001

Seppälä-Lindroos, 2002, Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men, J Clin Endocrinol Metab, 87, 3023, 10.1210/jcem.87.7.8638

Adiels, 2007, Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance, Diabetologia, 50, 2356, 10.1007/s00125-007-0790-1

Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41

Targher, 2009, Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome, Semin Thromb Hemost, 35, 277, 10.1055/s-0029-1222606

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Clark, 2003, The prevalence and etiology of elevated aminotransferase levels in the United States, Am J Gastroenterol, 98, 960, 10.1111/j.1572-0241.2003.07486.x

Brunt, 2011, Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings, Hepatology, 53, 810, 10.1002/hep.24127

Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x

Starley, 2010, Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection, Hepatology, 51, 1820, 10.1002/hep.23594

Charlton, 2011, Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States, Gastroenterology, 141, 1249, 10.1053/j.gastro.2011.06.061

Torres, 2012, Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil, Semin Liver Dis, 32, 30, 10.1055/s-0032-1306424

Yu, 2013, Obesity, insulin resistance, NASH and hepatocellular carcinoma, Semin Cancer Biol, 23, 483, 10.1016/j.semcancer.2013.07.003

Trépo, 2013, Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data, Hepatology

Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004

Koehler, 2012, Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study, J Hepatol, 57, 1305, 10.1016/j.jhep.2012.07.028

Lazo, 2013, Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994, Am J Epidemiol, 178, 38, 10.1093/aje/kws448

Patton, 2010, Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease, Am J Gastroenterol, 105, 2093, 10.1038/ajg.2010.152

Argo, 2009, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019

Sorrentino, 2010, Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension, Am J Gastroenterol, 105, 336, 10.1038/ajg.2009.587

Pais, 2013, A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver, J Hepatol, 59, 550, 10.1016/j.jhep.2013.04.027

Choi, 2013, Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study, Arch Med Res, 44, 115, 10.1016/j.arcmed.2013.01.007

Park, 2013, Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study, Hepatology, 57, 1378, 10.1002/hep.26183

Kotronen, 2009, A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans, Diabetologia, 52, 1056, 10.1007/s00125-009-1285-z

Yki-Järvinen, 2011, Pathophysiology of type 2 diabetes, 1740

Chen, 2012, Metabolic syndrome and gallstone disease, World J Gastroenterol, 18, 4215, 10.3748/wjg.v18.i31.4215

Nervi, 2013, Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?, Am J Gastroenterol, 108, 959, 10.1038/ajg.2013.84

Simonen, 2011, Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity, J Hepatol, 54, 153, 10.1016/j.jhep.2010.05.037

Min, 2012, Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease, Cell Metab, 15, 665, 10.1016/j.cmet.2012.04.004

Gastaldelli, 2007, Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects, Gastroenterology, 133, 496, 10.1053/j.gastro.2007.04.068

Fabbrini, 2008, Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease, Gastroenterology, 134, 424, 10.1053/j.gastro.2007.11.038

Adiels, 2008, Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome, Arterioscler Thromb Vasc Biol, 28, 1225, 10.1161/ATVBAHA.107.160192

Kotronen, 2008, Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes, Gastroenterology, 135, 122, 10.1053/j.gastro.2008.03.021

Tchernof, 2013, Pathophysiology of human visceral obesity: an update, Physiol Rev, 93, 359, 10.1152/physrev.00033.2011

Sung, 2014, Development of new fatty liver, or resolution of existing fatty liver, over five years of follow up, and risk of incident hypertension, J Hepatol, 10.1016/j.jhep.2014.01.009

Lehto, 2000, Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes, Diabetologia, 43, 148, 10.1007/s001250050023

Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3

Xu, 2013, Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study, Am J Gastroenterol, 108, 1299, 10.1038/ajg.2013.104

Centis, 2010, The effect of lifestyle changes in non-alcoholic fatty liver disease, Dig Dis, 28, 267, 10.1159/000282101

Rabl, 2012, The impact of bariatric surgery on nonalcoholic steatohepatitis, Semin Liver Dis, 32, 80, 10.1055/s-0032-1306428

Trayhurn, 2013, Hypoxia and adipose tissue function and dysfunction in obesity, Physiol Rev, 93, 1, 10.1152/physrev.00017.2012

Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246

Turer, 2012, Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study, J Clin Endocrinol Metab, 97, E982, 10.1210/jc.2011-3305

Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, 115, 1343, 10.1172/JCI23621

Turer, 2012, Adiponectin: mechanistic insights and clinical implications, Diabetologia, 55, 2319, 10.1007/s00125-012-2598-x

Machado, 2012, Gut microbiota and nonalcoholic fatty liver disease, Ann Hepatol, 11, 440, 10.1016/S1665-2681(19)31457-7

Frayn, 2000, Visceral fat and insulin resistance—causative or correlative?, Br J Nutr, 83, S71, 10.1017/S0007114500000982

Seidell, 1997, Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?, Int J Obes Relat Metab Disord, 21, 626, 10.1038/sj.ijo.0800467

Fabbrini, 2009, Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity, Proc Natl Acad Sci USA, 106, 15430, 10.1073/pnas.0904944106

Fabbrini, 2010, Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults, Gastroenterology, 139, 448, 10.1053/j.gastro.2010.04.056

Bray, 2004, Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity, Am J Clin Nutr, 79, 537, 10.1093/ajcn/79.4.537

Mozaffarian, 2011, Changes in diet and lifestyle and long-term weight gain in women and men, N Engl J Med, 364, 2392, 10.1056/NEJMoa1014296

de Koning, 2012, Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men, Circulation, 125, 1735, 10.1161/CIRCULATIONAHA.111.067017

Malik, 2010, Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis, Diabetes Care, 33, 2477, 10.2337/dc10-1079

Fung, 2009, Sweetened beverage consumption and risk of coronary heart disease in women, Am J Clin Nutr, 89, 1037, 10.3945/ajcn.2008.27140

Abdelmalek, 2010, Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1961, 10.1002/hep.23535

Lambert, 2013, Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease, Gastroenterology

Aarsland, 1998, Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men, J Lipid Res, 39, 1280, 10.1016/S0022-2275(20)32553-0

Kotronen, 2009, Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver, Diabetes, 58, 203, 10.2337/db08-1074

Westerbacka, 2010, Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease, Gastroenterology, 139, 1961, 10.1053/j.gastro.2010.06.064

Neuschwander-Tetri, 2013, Carbohydrate intake and nonalcoholic fatty liver disease, Curr Opin Clin Nutr Metab Care, 16, 446, 10.1097/MCO.0b013e328361c4d1

Sevastianova, 2012, Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans, Am J Clin Nutr, 96, 727, 10.3945/ajcn.112.038695

Mensink, 2003, Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials, Am J Clin Nutr, 77, 1146, 10.1093/ajcn/77.5.1146

Soman, 1979, Increased insulin sensitivity and insulin binding to monocytes after physical training, N Engl J Med, 301, 1200, 10.1056/NEJM197911293012203

Bae, 2012, Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults, PLoS One, 7, e46819, 10.1371/journal.pone.0046819

Johnson, 2012, Exercise and the liver: implications for therapy in fatty liver disorders, Semin Liver Dis, 32, 65, 10.1055/s-0032-1306427

Sullivan, 2012, Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease, Hepatology, 55, 1738, 10.1002/hep.25548

Kirk, 2009, Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction, Gastroenterology, 136, 1552, 10.1053/j.gastro.2009.01.048

Rabøl, 2011, Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals, Proc Natl Acad Sci USA, 108, 13705, 10.1073/pnas.1110105108

Schwimmer, 2009, Heritability of nonalcoholic fatty liver disease, Gastroenterology, 136, 1585, 10.1053/j.gastro.2009.01.050

Makkonen, 2009, Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins, J Hepatol, 50, 1035, 10.1016/j.jhep.2008.12.025

Weston, 2005, Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease, Hepatology, 41, 372, 10.1002/hep.20554

Lorenzo, 2006, Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects, Diabetes Care, 29, 685, 10.2337/diacare.29.03.06.dc05-1796

Speliotes, 2011, Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits, PLoS Genet, 7, e1001324, 10.1371/journal.pgen.1001324

Chambers, 2011, Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma, Nat Genet, 43, 1131, 10.1038/ng.970

Santoro, 2012, Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents, Hepatology, 55, 781, 10.1002/hep.24806

Hernaez, 2013, Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey, Clin Gastroenterol Hepatol, 11, 1183, 10.1016/j.cgh.2013.02.011

Palmer, 2013, Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent, Hepatology, 58, 966, 10.1002/hep.26440

Gorden, 2013, Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity, Hum Hered, 75, 34, 10.1159/000346195

Norris, 2012, Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome, Arterioscler Thromb Vasc Biol, 32, 2091, 10.1161/ATVBAHA.112.255463

Jean-Louis, 2008, Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components, J Clin Sleep Med, 4, 261, 10.5664/jcsm.27191

Musso, 2013, Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis, Obes Rev, 14, 417, 10.1111/obr.12020

Sookoian, 2013, Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis, Obes Surg, 23, 1815, 10.1007/s11695-013-0981-4

Sun, 2013, Fibrosis and adipose tissue dysfunction, Cell Metab, 18, 470, 10.1016/j.cmet.2013.06.016

Huang, 2012, Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome, Curr Opin Endocrinol Diabetes Obes, 19, 512, 10.1097/MED.0b013e32835a000e

Jones, 2012, Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance, J Clin Endocrinol Metab, 97, 3709, 10.1210/jc.2012-1382

Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, 40, 1461, 10.1038/ng.257

Sookoian, 2011, Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease, Hepatology, 53, 1883, 10.1002/hep.24283

Anstee, 2013, The genetics of NAFLD, Nat Rev Gastroenterol Hepatol, 10, 645, 10.1038/nrgastro.2013.182

Li, 2012, Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population, BMC Med Genet, 13, 113, 10.1186/1471-2350-13-113

Peng, 2012, Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population, PLoS One, 7, e50256, 10.1371/journal.pone.0050256

Lin, 2013, A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children, Am J Clin Nutr, 97, 326, 10.3945/ajcn.112.046417

Cox, 2011, Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus, Diabetes Metab, 37, 452, 10.1016/j.diabet.2011.05.001

Kantartzis, 2009, Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene, Diabetes, 58, 2616, 10.2337/db09-0279

Huang, 2010, A feed-forward loop amplifies nutritional regulation of PNPLA3, Proc Natl Acad Sci USA, 107, 7892, 10.1073/pnas.1003585107

Huang, 2011, Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease, J Biol Chem, 286, 37085, 10.1074/jbc.M111.290114

Kumari, 2012, Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase, Cell Metab, 15, 691, 10.1016/j.cmet.2012.04.008

Romeo, 2010, Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent, Int J Obes (Lond), 34, 190, 10.1038/ijo.2009.216

Petit, 2010, Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes, J Clin Endocrinol Metab, 95, E430, 10.1210/jc.2010-0814

Li, 2011, I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population, Hepatology, 54, 2275, 10.1002/hep.24567

Sookoian, 2009, A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity, J Lipid Res, 50, 2111, 10.1194/jlr.P900013-JLR200

Valenti, 2010, I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease, Hepatology, 52, 1274, 10.1002/hep.23823

Krarup, 2012, The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation, PLoS One, 7, e40376, 10.1371/journal.pone.0040376

Kitamoto, 2013, Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan, Hum Genet, 132, 783, 10.1007/s00439-013-1294-3

Palmer, 2012, Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant, PLoS One, 7, e39362, 10.1371/journal.pone.0039362

Hyysalo, 2014, Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity, Diabetes, 63, 312, 10.2337/db13-0774

Lallukka, 2013, Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3, Diabetologia, 56, 886, 10.1007/s00125-013-2829-9

Wang, 2011, The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population, Liver Int, 31, 1326, 10.1111/j.1478-3231.2011.02526.x

Sevastianova, 2011, Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans, Am J Clin Nutr, 94, 104, 10.3945/ajcn.111.012369

Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161

Magkos, 2010, Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin, Diabetes Obes Metab, 12, 584, 10.1111/j.1463-1326.2009.01191.x